Business Context and Reporting Period
This Form 8-K is filed by The Clorox Company on February 2, 2005. The report addresses a change in the accounting treatment regarding a transaction completed on November 22, 2004, with Henkel KGaA and HC Investments, Inc. (collectively "Henkel").
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references pro forma financial information related to the Henkel transaction that was previously disclosed in an earlier Form 8-K filed in November 2004, but does not restate those figures here.
Material Changes
The primary material change disclosed is a revision in the accounting treatment of the impact of the Henkel transaction. This change was announced via a press release issued on February 2, 2005, which is attached as Exhibit 99-1 to this filing.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors. The document focuses solely on the procedural update regarding the accounting methodology for the prior transaction.
Investor Verification Checklist
- Review the press release attached as Exhibit 99-1 for details on the specific accounting change.
- Examine the November 22, 2004, Form 8-K to understand the original pro forma financial information for the Henkel transaction.
- Verify how the change in accounting treatment impacts previously reported financial statements.